|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 USD | -2.61% |
|
+2.76% | -25.13% |
| Market Cap | 397M 345M 321M 295M 556M 37.86B 565M 3.78B 1.48B 18.85B 1.49B 1.46B 63.19B | P/E 2026 * |
-1.68x | P/E 2027 * | -2.36x |
|---|---|---|---|---|---|
| Enterprise Value | 357M 310M 289M 265M 501M 34.08B 509M 3.41B 1.34B 16.97B 1.34B 1.31B 56.89B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.33x |
| Free-Float |
3.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Autolus Therapeutics plc
| 1 day | -2.61% | ||
| 1 week | +2.76% | ||
| 1 month | -5.70% | ||
| 3 months | +1.36% | ||
| 6 months | +8.76% | ||
| Current year | -25.13% |
| 1 week | 1.41 | 1.58 | |
| 1 month | 1.38 | 1.74 | |
| Current year | 1.18 | 2.07 | |
| 1 year | 1.18 | 2.52 | |
| 3 years | 1.1 | 7.45 | |
| 5 years | 1.1 | 7.9 | |
| 10 years | 1.1 | 53.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Pulé
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/09/2014 |
Christian Itin
CEO | Chief Executive Officer | 61 | 01/03/2016 |
Robert Dolski
DFI | Director of Finance/CFO | 56 | 07/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Itin
CHM | Chairman | 61 | 01/10/2014 |
John Berriman
BRD | Director/Board Member | 78 | 01/08/2014 |
Cynthia Butitta
BRD | Director/Board Member | 71 | 01/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/6/26 | Free | Director | 79,167 | 0.0477% | ||
| 18/3/26 | Other | Controller/Auditor | 331,000 | 0.1992% | ||
| 18/3/26 | Other | General Counsel | 780,818 | 0.4700% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.61% | +2.76% | -36.60% | -52.70% | 397M | ||
| +3.29% | +16.25% | +36.46% | +3.19% | 76.15B | ||
| +2.72% | -9.39% | +20.58% | +172.43% | 48.89B | ||
| -2.75% | +48.50% | +48.50% | +48.50% | 47.83B | ||
| -3.81% | +7.74% | -53.40% | -54.31% | 41.37B | ||
| -2.40% | +0.38% | +53.81% | -24.64% | 29.99B | ||
| -2.82% | +1.57% | +58.12% | +87.66% | 24.23B | ||
| -5.35% | +1.39% | +98.59% | -51.89% | 21.89B | ||
| -1.59% | -3.61% | -6.77% | +150.58% | 19.25B | ||
| -0.42% | +2.89% | +77.99% | +128.67% | 17.14B | ||
| Average | -1.57% | +1.61% | +29.73% | +40.75% | 32.71B | |
| Weighted average by Cap. | -0.62% | +2.98% | +31.38% | +43.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 112M 104M 95.52M 180M 12.27B 183M 1.23B 481M 6.11B 483M 472M 20.49B | 191M 166M 155M 142M 268M 18.23B 272M 1.82B 715M 9.08B 717M 701M 30.43B |
| Net income | -242M -211M -196M -180M -340M -23.14B -345M -2.31B -907M -11.52B -910M -890M -38.62B | -185M -161M -149M -137M -259M -17.63B -263M -1.76B -691M -8.78B -694M -678M -29.44B |
| Net Debt | -39.53M -34.36M -31.99M -29.37M -55.46M -3.77B -56.32M -377M -148M -1.88B -148M -145M -6.3B | 48.41M 42.09M 39.17M 35.97M 67.92M 4.62B 68.97M 462M 181M 2.3B 182M 178M 7.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | USD 1.490 | -2.61% | 815,256 |
| 30/07/26 | USD 1.530 | +4.79% | 1,745,722 |
| 29/07/26 | USD 1.460 | +0.69% | 651,988 |
| 28/07/26 | USD 1.450 | -0.68% | 527,891 |
| 27/07/26 | USD 1.460 | +0.69% | 506,155 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AUTL Stock
Select your edition
All financial news and data tailored to specific country editions

















